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Shigatoxin encoding Bacteriophage 
φ24B modulates bacterial 
metabolism to raise antimicrobial 
tolerance
G. S. Holt1, J. K. Lodge1, A. J. McCarthy2, A. K. Graham1, G. Young1, S. H. Bridge1, 
A. K. Brown3, M. Veses-Garcia2, C. V. Lanyon1, A. Sails4, H. E. Allison2,* & D. L. Smith1,*
How temperate bacteriophages play a role in microbial infection and disease progression is not fully 
understood. They do this in part by carrying genes that promote positive evolutionary selection for the 
lysogen. Using Biolog phenotype microarrays and comparative metabolite profiling we demonstrate 
the impact of the well-characterised Shiga toxin-prophage φ24B on its Escherichia coli host MC1061. As 
a lysogen, the prophage alters the bacterial physiology by increasing the rates of respiration and cell 
proliferation. This is the first reported study detailing phage-mediated control of the E. coli biotin and 
fatty acid synthesis that is rate limiting to cell growth. Through φ24B conversion the lysogen also gains 
increased antimicrobial tolerance to chloroxylenol and 8-hydroxyquinoline. Distinct metabolite profiles 
discriminate between MC1061 and the φ24B lysogen in standard culture, and when treated with 2 
antimicrobials. This is also the first reported use of metabolite profiling to characterise the physiological 
impact of lysogeny under antimicrobial pressure. We propose that temperate phages do not need to 
carry antimicrobial resistance genes to play a significant role in tolerance to antimicrobials.
Colonisation by Shiga toxin-encoding Escherichia coli (STEC) causes a potentially fatal gastrointestinal infec-
tion in humans. There are currently > 500 different characterised STEC serogroups that cause disease including 
O157:H7 and more recently O104:H41,2. Symptoms of STEC infection can vary from bloody diarrhoea through to 
haemorrhagic colitis, thrombotic thrombocytopaenic purpura (TTP) and haemolytic-uraemic syndrome (HUS), 
the latter can be fatal3,4. STEC is a zoonotic infection transmitted from an animal reservoir via contaminated food 
or water5. Shiga toxins are responsible for the severe downstream sequelae due to high cytotoxicity to human 
renal microvascular endothelial cells4,6. Importantly, the genes encoding Shiga toxin (Stx) are disseminated by 
temperate bacteriophages.
Stx-phages enter one of two replication pathways: a productive lytic life cycle or a more passive lysogenic 
cycle where the prophage is replicated by the bacterium as any other genetic loci. The lytic-lysogen decision of 
lambdoid-like bacteriophages is regulated by early gene expression and sequential binding of proteins to a well 
characterised genetic switch7–9.
The co-evolutionary interaction between a phage and its bacterial host is dynamic, with interplay linked to 
rounds of inhibition, selection and evolution, often referred to as an ‘arms race’10. Smith et al.11 used a multi-loci 
PCR typing approach to demonstrate that no two Stx phage isolates had the same genotype11. This heteroge-
neity is further supported by Bonanno et al.12 who identified multiple Stx-phage morphologies not previously 
reported12. Stx-phages are closely related to bacteriophage lambda, with a comparable genome organisation. In 
comparison to lambda, Stx-phages carry significantly larger amounts of DNA (~20–25 Kbp), with up to 73% of 
the genome and putative coding genes having no known function when analysed at either the nucleotide or pro-
tein level13. Nevertheless these genes are well conserved across many Stx-phages and thus likely to be important 
to the biology of the phage or its bacterial host13. Upon phage infection and conversion to a lysogen, genes that are 
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accessory to the core biology of the phage may offer a selective advantage to the host. Mis-excision, mis-packaging 
of phage DNA14, and recombination15 play a large role in phage genome variation. This may leave phage DNA 
regions, remnant or cryptic prophages, that positively impact on the selection and survival of both the phage and 
the bacterium16. This is further supported by the common occurrence of prophage regions, usually multiple, in 
the chromosomes of many bacterial pathogens17.
There are a number of features of the Shigatoxigenic phage vB_EcoPφ 24B or φ24B that are particularly relevant 
to the success and persistence of Stx prophages in E. coli. In contrast to the lambda infection model, φ 24B can mul-
tiply infect a bacterial host18–20. Stx-phages have been isolated from a wide variety of environments where E. coli is 
present, and this has undoubtedly been promoted by the use of an essential outer membrane protein BamA as the 
adsorption site21. This interaction is conserved in Stx-phages as the incidence of the tail and host recognition pro-
tein is widespread21. φ 24B has also been shown to survive well in compost models22, and infectivity after 30 days in 
bovine manure and slurry23. φ 24B is genetically similar to phages isolated from sporadic outbreaks of STEC with 
high virulence and therefore a good model of the viruses circulating in E. coli populations in the environment13.
The ability of lambdoid like phages to increase virulence by carriage of toxins in their accessory genome24 is 
well described e.g. the cholera toxin (CTX) carried by Vibrio cholera phage25,26. In Stx-phage genomes the shiga-
toxin genes are always located at the same position, upstream of the Q antiterminator gene therefore organisation 
and gene location is important27. It has been hypothesised that presence of stx also offers selection and stability 
for the lysogens28. Colon et al.29 observed that Stx-prophages show greater levels of spontaneous induction than 
lambda but this more readily correlates to Rec dependent and independent control of the CI repressor protein 
rather than presence or absence of stx29.
There are other accessory genes that are seemingly superfluous to viral replication have been shown to aid 
microbial selection against environmental stress. Examples include: antibiotic resistance30,31, acid tolerance32,33 
and polylysogeny34. Phage gene expression has also been shown to aid adhesion and colonisation, for example the 
expression of the λ -encoded lom gene promotes adhesion to buccal epithelial cells35, and the λ -encoded bor con-
fers serum resistance36. Other phage encoded virulence traits include exotoxin production in E. coli37 and increase 
in bacterial invasion via Staphylococcus phage encoded kinase that influences fibrinolysis38. Bacteriophage φ 24B 
has also been shown to encode a mi-RNA in the lom region that alters expression of anti-repressor d-ant and 
downstream activity of CI, leading to rapid induction39. Tree et al.40 identified 55 prophage regions encoding 
small regulatory RNA within the Sakai E. coli O157:H7 strain40. These small prophage anti-sRNA had the ability 
to form complexes or mimic core genome regulatory sRNA to aid selective advantage to the bacterial host in 
bovine rectal mucus. Stx-phage φ 24B shows 98% sequence homology at the nucleotide level to the remnant Stx2 
phage present in the Sakai genome13.
The function of the large numbers of hypothetical proteins encoded by φ 24B and other converting phage is dif-
ficult to determine, and a focus of this study, as gene expression or interaction may be specific to an environment 
or subject to selective pressure. Therefore, current approaches in vitro using synchronous cultures and standard 
laboratory conditions to investigate the role of these prophages are challenging. The function of these hypothet-
ical gene products and how they impact the host in either an advantageous or deleterious way may be missed. In 
this study we focus on phage mediated antimicrobial tolerance to antibiotics found in the livestock farm setting 
which is the primary reservoir of pathogenic shigatoxigenic E. coli.
Our principal aim was to identify how infection and integration of φ 24B changes the microbial physiology, 
and how phage conversion aids selection compared to its naïve counterpart. This study demonstrates an increase 
in cell proliferation in standard culture, increased respiration activity using the Biolog phenotypic array and 
antimicrobial tolerance that is not linked to an identifiable resistance gene-cassette. The Biolog phenotypic array 
is a good tool for rapidly identifying phenotypic changes in the respiration profiles of bacteria41,42. This study also 
presents an untargeted metabolomics approach to reveal key phage-mediated differences in metabolism directly 
linked to biotin and fatty acid synthesis. Interestingly, we show that integration of φ 24B into its primary integra-
tion site located 250 bp upstream of the IntS gene43 allows converted E. coli MC1061 to grow using alternative 
sources of phosphate compared to the naïve bacterial host. We show for the first time unique changes in bacterial 
metabolite profiles on phage conversion in response to sub-inhibitory concentrations of antimicrobial agents.
Results
φ24B integration increases cell proliferation. Growth rates of bacteria can differ due to a range of envi-
ronmental parameters. To investigate the impact of φ 24B on E. coli, viable cell counts were determined during 
growth comparing E. coli B strain MC1061 to single and double lysogens, the latter integrated into separate loca-
tions in the MC1061 chromosome43. Under standard growth conditions, the single and double lysogens showed 
significantly higher cell numbers compared to the naïve MC1061 (> 200%, Fig. 1). This alongside a statistically 
significant increase in doubling time of 18 minutes for the single lysogen compared to 20 minutes for the naïve 
MC1061 (p < 0.006), calculated from each growth curve (data not shown, n = 9). As the cultures reached mid 
to late exponential growth, the differences in growth rates diminished (Fig. 1). The greatest difference in growth 
was identified in early growth (Fig. 1). This was supported by a shorter lag time in the single and double lysogen 
compared to MC1061 with a 0.5 and 1.8-fold increase respectively in cell number after the first hour of growth. 
Stationary phase in the double lysogen is achieved earlier compared to MC1061 and the single lysogen as nutri-
ents are utilised rapidly alongside the accumulation of inhibitory components of growth.
φ24B integration alters utilisation of different mono-phosphates and inability to respire using 
β-D-Allose. To explore the single lysogen related differences in cell respiration during growth we used the 
Biolog Phenotype MicroArray. This determined functional changes in respiration and metabolism resulting from 
phage conversion over a 48 h period with recordings taken every 15 min. The lysogen acquired the ability to 
respire and grow utilising uridine-2-monophosphate (U-2-P) when compared to the naïve MC1061 (SI Fig. 1, 
www.nature.com/scientificreports/
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panel A). Phage mediated subversion of pyrimidine and purine synthesis by lytic phages has previously been 
reported and will be discussed later. Conversely, integration of the phage inhibited the lysogens ability to use 
D-Allose for respiration.
φ24B integration alters resistance to osmotic stress or antimicrobials. Again using the Biolog phe-
notypic array the single lysogen is able to tolerate a range of antimicrobial agents that have both extracellular and 
intracellular targets (Fig. 2). The respiration curves derived for this experiment are provided in the supplementary 
information (SI - Figs 1 and 2). Tests showing differences in respiration profile were determined in the presence of 
22 antimicrobials and 7 increases in salt concentration (SI Table 2). Of these 29 different tests, the lysogen showed 
a level of tolerance to 17 antimicrobials (SI Table 2). Data presented in Fig. 2 (n = 3) are comparisons of the area 
under the respiration curve illustrating those that were altered significantly. φ 24B infection promotes tolerance to 
8-hydroxyquinoline (P < 0.000), chloroxylenol (P < 0.0037), and cefmetazole (P < 0.0026), cefoxitin, (P < 0.015) 
cefemendole (P < 0.0239) and amoxicillin (P < 0.057). Integration of φ 24B into the primary site 250 bp upstream 
of IntS inhibits respiration utilising B-D-allose. Lysogeny also limits cell respiration in the presence of oxolinic 
acid although this is linked to phage induction as the cellular target is DNA gyrase. Inhibition of DNA gyrase has 
been previously shown to stimulate temperate phages to the lytic life cycle as cellular stress stimulates RecA, LexA 
and proteolytic cleavage of the repressor protein promoting phage induction44.
φ24B integration increases MC1061 tolerance to sub-inhibitory concentrations of chlorox-
ylenol and 8-hydroxyquinoline. To better understand the level of antimicrobial tolerance of the single 
lysogen, we first determined sub-inhibitory concentrations (SIC) against both MC1061 and the lysogen that 
reduce cell growth by ~60%. The antimicrobials chloroxylenol, oxolinic acid and 8-hydroxyquinoline were 
selected to validate the Biolog data. Prior to comparison, an approximate SIC range was determined for MC1061 
utilising each of the 3 test drugs. Figure 3 illustrates increased tolerance by the lysogen in the presence of chlorox-
ylenol and 8-hydroxyquinoline. Conversely, the naïve host shows increased tolerance compared to the lysogen in 
the presence of oxolinic acid. This also offers a positive control for the assay as oxolinic acid targets DNA gyrase 
and therefore stimulates phage induction26. Phage induction was confirmed by the presence of free phage com-
pared to the un- induced control (data not shown).
Metabolic profiles comparing naïve MC1061 to φ24B Lysogen. We used an untargeted metabolite 
profiling approach using high resolution LC-MS (≤1 ppm mass accuracy in full scan) to determine metabolic 
differences between bacterial host and lysogen during growth and when challenged with a sub-inhibitory concen-
tration of test antibiotic. To broadly compare findings, significant metabolic differences (p < 0.05) were observed 
between both growth phase and antimicrobial challenge. In total, > 11 K ion features or possible metabolites were 
determined across all of the different tests performed. Of these 81 showed discrimination between the naïve 
MC1061 and the φ 24B lysogen that had clean chromatogram peaks and < 5% coefficient variable (CV) (SI Table 3). 
These 81 metabolites that show differences can be further stratified to each test.
Figure 1. Clustered column graph representing percentage increase in cell proliferation of single 
(φ24B::ΔKan, dark grey) and double (φ24B::ΔKan, φ24B::ΔCat, light grey) MC1061 lysogens. Cultures 
were grown at 37 °C (CFU.ml) and samples taken over a 7 hour period including experimental and technical 
replicates (n = 9). Percentage increases or decreases show differences in growth of the lysogens compared to the 
uninfected MC1061 represented here as 0 on the x axis. Significance threshold P values ***< 0.001, **< 0.01, 
*<0.05, significance below the x axis demonstrates greater growth from the Naïve host.
www.nature.com/scientificreports/
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The metabolite data was analysed using supervised and non-supervised methods of multivariate analysis. 
Principal Component Analysis was first employed to visualise trends in the dataset and identify potential outliers. 
To further interrogate the data, Partial-Least Squared Discriminant Analysis models (PLS-DA) were generated 
and score plots are shown in (Fig. 4A–C). The PLS-DA models for both hydroxyquinoline and chloroxylenol 
conditions score plots had good discriminating ability, establishing the metabolic differences between the lysogen 
and naïve host. During standard growth conditions component 1 failed to discriminate: Q2 − 0.556, R2Y 0.262, as 
R2Y and Q2 < 0.5, although certain metabolites showed significant differences between the lysogen and MC1061. 
The 8-hydroxyquinoline component 1: Q2 0.74, R2Y 0.89 and the chloroxylenol component 1: Q2 0.802, R2Y 
0.923 were both discriminatory with an R2Y and Q2 > 0.5. Further model statistics can be found in the supple-
mentary information SI Table 5. Stx-phage φ 24B has been previously shown to undergo spontaneous induction27 
and may impact the metabolite profile through sequestration of host function and movement to lysis. We there-
fore compared the metabolite profiles of both the lysogen and MC1061 with a phage inducing agent, oxolinic acid 
(DNA gyrase inhibitor). No correlation was seen between metabolite profiles of the lysogen or MC1061 when 
compared to that of the lysogen undergoing induction with oxolinic acid (data not shown).
Figure 2. A comparison of Area Under the Respiration Curve (AURC) data from the Biolog bacterial 
phenotypic microarray. Data plotted shows the addition of supplemented nutrients or chemical challenge 
showed statistically significant difference in rates of respiration between the lysogen and naïve MC1061 host 
(for P values see SI Table 2). Arbitrary Omnilog fluorescence values (y-axis) show differences between the naïve 
MC1061 (light grey) host and the lysogen (dark grey) over a 47.5 h time period (n = 3). Error bars represent 
SEM. Graphs A-F show significantly higher amount of respiration of the lysogen compared to the naïve host 
under the following conditions; (A) U-2-monophosphate, (B) 8-hydroxyquinoline, (C) chloroxylenol, (D) 
cefoxitin, (E) cefomendole and (F) amoxacillin. Graphs (G–I) show mean AURC values where growth on 
different carbon sources or chemical challenge that has a detrimental effect on the respiration of MC1061 when 
converted by φ 24B, these inculde; (G) β _D-Allose, (H) ofloxacin and (I) oxolinic acid.
www.nature.com/scientificreports/
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φ24B integration alters the metabolite profile of MC1061 in standard growth conditions. Out 
of the 81 discriminatory metabolites determined in this study, only 16 were shown to discriminate between the 
naïve host and single lysogen under standard culture conditions. Of these 16 metabolites 4 were found in higher 
levels in the lysogen. This suggests that the lysogen down regulates certain metabolic functions or is directing 
metabolism along a different pathway, or both. It is likely to support the change in biology we report in this work 
and increased rates of early growth by the lysogen.
Early growth in the lysogen demonstrates an observable difference in metabolic profile compared to the naïve 
MC1061. Under standard growth conditions during early growth, 5 metabolites in total were shown to discrim-
inate between the naïve MC1061 and lysogen. Of these, 1 was higher compared to the naïve control (Fig. 3 SI). 
During stationary phase, in standard growth conditions, only 9 metabolites in total showed significant difference 
and all were found in lower levels in the lysogen.
Figure 3. Response in growth of both MC1061 (light grey) and the φ 24B lysogen (Dark grey) to an increasing 
concentration of (A) 8-hydroxyquinoline, (B) chloroxylenol, and (C) oxolinic acid. Bacterial growth was 
measured by increase in optical density at 600 nm after 18 hours growth at 37 °C, as per original Biolog assay. 
Error bars represent the standard error of the mean (SEM) (n = 12). Significance represented by (P) thresholds; 
***< 0.001, **< 0.01, *< 0.05.
www.nature.com/scientificreports/
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As phage-mediated metabolic differences are present during standard culture, the differences in metabolite 
profiles under challenge with sub-inhibitory concentrations of 8-hydroxyquinoline and chloroxylenol were tested 
(Fig. 2B,C). The previous Biolog results showed that the lysogen displays a tolerance to these 2 antibiotics.
φ24B integration alters the metabolite profile of MC1061 during growth under sub-inhibitory 
concentrations of 8-hydroxyquinoline. Upon treatment with 8-hydroxyquinoline, there were 29 metab-
olites that showed significant difference between the naïve MC1061 and single lysogen. Of these 29 metabolites, 
22 were found in higher levels in the lysogen. Early growth phase in the lysogen demonstrates an observable dif-
ference in metabolite profile compared to naïve MC1061. Under 8-hydroxyquinoline stress during early growth, 
6 metabolites in total were shown to discriminate between the naïve MC1061 and lysogen. Of these, 5 were higher 
compared to the naïve control (Fig. 3 SI).
φ24B integration alters the metabolite profile of MC1061 during growth under sub-inhibitory 
concentrations of chloroxylenol. Under chloroxylenol treatment, 41 metabolites showed significant dif-
ferences between the naïve MC1061 and lysogen. Of these 41, the lysogen had 22 metabolites with significantly 
higher levels compared to the naïve host. Early growth phase in the lysogen demonstrates an observable differ-
ence in metabolic change compared to the naïve MC1061. Under chloroxylenol stress during early growth, 13 
Figure 4. (A–C) The metabolite profiles of MC1061 versus lysogen and multivariate analysis using partial least 
discriminant analysis (PLS-DA). The panels represent score plots from PLS-DA models of: (A) Standard growth 
conditions, and supplementation with (B) 8-hydroxyquinoline and (C) chloroxylenol, between the naïve host 
(light grey spot) and lysogen (dark grey spot), the model discriminatory parameters for the PLS-DA analysis are 
described in the results section and in SI Table 5.
www.nature.com/scientificreports/
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metabolites in total were shown to discriminate between the naïve MC1061 and lysogen. Of these, 9 were higher 
compared to the naïve control (Fig. 3 SI).
Alteration in metabolomics profile and antimicrobial tolerance is not linked to kanamycin 
resistance selective marker used to detoxify φ24B. The kanamycin gene (aph3) used to detoxify the 
φ 24B phage18 is used as a selective marker only prior to experimentation. As there is no consistency in the meta-
bolic profiles when the lysogen cultures are treated with the 2 different antimicrobials this cannot be driven by φ 
24B encoding aph3. The metabolite profiles are also discriminatory to each of the 2 antimicrobials tested.
Characterising the metabolites that discriminate between the naïve MC1061 and φ24B 
lysogen. The discriminatory metabolites determined from each test were compared with metabolite data-
bases and were putatively identified based on exact mass and empirical formula (LCMS methods section). 
The identity of each metabolite was confirmed using fragmentation analysis using a secondary MS/MS stage. 
Identities with fragment similarity were found for 58 of the 81 metabolites discriminating between the naïve and 
lysogen. We focus here on 6 particular metabolites as they have robust identities from fragmentation patterns, 
retention times, and low accurate mass error (PPM), relating to known curated bacterial metabolites (Table 4 SI). 
The 6 metabolites are: hexadecanoic acid (a fatty acid that is utilised in the construction of lipid A), sphinganine 
(putative kinase), 5-Methyluridine (nucleotide synthesis, specifically pyrimidine), ophthalmic acid (glutathione 
analogue), pimelic acid and FAPy-Adenine, with PPM error margins of 0 ± 1 (0.17, − 0.64, 0.45, 1.31, 0.56 and 
− 1.00, respectively).
The lysogen has significantly higher intensity levels of pimelic acid under all tests, specifically during early 
growth (Fig. 5). FAPy-Adenine, a bacterial stress marker45, is only seen in stressed conditions in these analyses, 
with the lysogen expressing significantly lower intensity during early growth and higher intensity at stationary 
phase growth (Fig. 5). Hexadecanoic acid is identified in significantly higher abundance under cellular stress of 
chloroxylenol, and is further increased in the lysogen during early growth (P = 0.04). Metabolite sphinganine is 
present under standard conditions in higher intensity in the naïve MC1061. When challenged with chloroxyle-
nol, intensity levels of sphinganine were undetectable in both naïve and lysogen during early growth. During 
mid-exponential and stationary phase growth under choloroxylenol test there is > 100 fold increase in intensity 
of sphinganine in both the naïve and lysogen. 5-Methyluridine is present at stationary phase in all conditions, and 
is also identified in higher intensity when challenged with both antibiotics. Ophthalmic acid was present at all 
stages of growth under standard conditions where the lysogen shows lower intensity at early and mid-growth, and 
higher levels at stationary phase. When treated with either antimicrobial agent, ophthalmic acid was only present 
at stationary growth, with significantly higher intensity found in the lysogen (P = 0.001). During standard culture, 
there are 16 metabolites responsible for the differences seen between the core metabolic profiles of naïve host and 
lysogen during the 3 growth phases. Importantly 10 of these, including pimelic acid, are also present when the 
lysogen is challenged with chloroxylenol and 8-hydroxyquinoline.
In the absence of antibiotics, the metabolite profile shows less discrimination between the lysogen and host 
at the 3 stages of growth by PLS-DA (Fig. 4A). Changes in individual metabolite abundances were measured as 
before (Figs 4 and 6), and > 100 were deemed possible biologically relevant metabolites. From the confirmed 
compounds, a total of 16 metabolites (SI Table 3) were shown to discriminate between MC1061 and the φ 24B 
lysogen.
We further analysed these data using Hierarchical cluster analysis (HCA) and Euclidean dissimilarity matrix 
(DM) to create a heatmap that discriminates between 81 metabolites across all tests in this study (Fig. 6). The 
unsupervised heatmap shows that the metabolic profiles have separated by condition.
Figure 6 illustrates differences between the metabolic profiles of the naïve MC1061 and φ 24B lysogen when 
comparing both test antimicrobials and the standard culture conditions. Firstly there is the greatest dissimilarity 
when the naïve host or lysogen has been treated with a sub-inhibitory concentration of chloroxylenol. Within this 
grouping the naïve host shows the greatest difference in profile at stationary phase for the treatment group. The 
chloroxylenol group is further stratified by whether the phage is present or absent. Presence of the phage offers the 
most dissimilar metabolic profile under this antimicrobial challenge. Treatment with 8-hydroxyquinoline has less 
impact on the metabolic profiles, yet the antimicrobial tolerance is still marked. The difference is also less marked 
as the profiles are stratified by growth phase rather than presence or absence of phage. Importantly, in Fig. 6 dif-
ferences between the 81 metabolites in the naïve host and lysogen without challenging with an antimicrobial are 
still apparent.
Discussion
The accessory genome of bacteria promoted through horizontal gene transfer is important in understanding 
how mobile genetic elements aid selection in the environment. Metagenomics of DNA viruses in environmen-
tal and clinical samples has revealed a wide range of antimicrobial resistance genes (ARGs)46–48. Enault et al.49 
demonstrate that caution is needed as ARGs are over-estimated and therefore rarely found in phage genomes 
and that this over-estimation was further supported by functionality49. We here propose a different mechanism 
promoted by Stx-phage φ 24B, through infection and subversion of the cell physiology, promoting tolerance to 
sub-inhibitory concentrations of antimicrobials 8-hydroxyquinoline and chloroxylenol. Importantly, we show 
here that this tolerance is to antimicrobials commonly used globally in the farming industry. Chloroxylenol 
is widely used in detergent based products l, for the direct treatment of livestock e.g. bovine teat treatment50. 
Similarly 8-hydroxyquinoline has a broad antimicrobial activity with agricultural use due to its potency against 
insects, fungi, and bacteria51.
DeSmet et al., (2016) illustrated metabolomic differences during phage infection of P. aeruginosa52, whereas 
this is the first reported use of a metabolic profiling approach to characterise the impact of temperate phage 
www.nature.com/scientificreports/
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infection on the physiology of the bacteria under antimicrobial pressure. The impact of prophage should not be 
underestimated as basis for metabolic variation and selection for the bacterial host by heightening or dampening 
cellular response to stress. With the altered metabolic profile of the φ 24B lysogen and increased levels of biotin 
concentration and fatty acid intensities it leads to the hypothesis that altered growth and lipids may play a role in 
altering the cell surface that promotes antimicrobial exclusion.
The metabolite pimelic acid is a precursor for the majority of the carbon atoms of biotin53. Biotin plays a cru-
cial role in cell metabolism via carboxylation and decarboxylation reactions. Beyond its function as a cofactor for 
carboxylases, biotin also plays a role in gene regulation in mammals54. Unfortunately the mechanism of its action 
in E. coli is relatively unknown. However it has been shown that the E. coli BioC–BioH pathway uses a methylation 
and demethylation strategy to complete the necessary pimeloyl moiety53. This methylation approach disguises the 
biotin synthetic intermediates such that they become substrates for the fatty acid synthetic pathway, and once the 
pimeloyl moiety is complete it is demethylated53. We show here that the φ 24B prophage has a significant upreg-
ulatory effect on biotin that links to other physiological pathways including fatty acid synthesis53. Differences in 
pimelic acid intensities between lysogen and naïve host were greatest during early growth (Figs 1A,2B, 3A and 5A), 
which correlates with the differences observed in growth rates during the first 2.5 hours of culture (Fig. 1). 
This is associated with a ~3 fold increase in the level of biotin present per cell at mid-exponential growth phase 
Figure 5. Biotin concentration, FAPy-Adenine and pimelic acid intensity showing significant biological 
differences between naïve host and lysogen during growth and antimicrobial challenge. (A1): Changes 
in cellular stress marker FAPy-Adenine abundances under the challenge of chloroxylenol at early, mid and 
stationary growth between the lysogen (dark grey) and naive Host (light grey). (B1): Average pimelic acid 
abundance under chloroxylenol at early, mid and stationary growth between the lysogen and naive Host. (A2): 
Average FAPy-Adenine abundances under selective pressure of 8-hydroxyquinoline at early, mid and stationary 
growth between the lysogen and naive MC1061. (B2): Average pimelic acid abundances under challenge with 
8-hydroxyquinoline at early, mid and stationary growth between the lysogen and naive Host. (A3): Average 
pimelic acid abundances under standard conditions at early, mid and stationary growth between the lysogen 
and naive Host. (B3): Variance in the amounts of Biotin present in samples of Ф24B lysogen and MC1061 naïve 
Host. Error bars derived from standard error of the mean (n = 3). Biotin Quantitation test performed using 
BioVision® quantitation kit (7.5) using a modified protocol. Two tailed significance represented by ***< 0.001, 
**< 0.01, *< 0.05, key: *Inc. = Increase, *expo = exponential growth.
www.nature.com/scientificreports/
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(Fig. 5B3), which correlates to metabolite profiling for pimelic acid. This is the first time a phage has been shown 
to drive the biotin pathway.
The Biolog data confirmed significant differences in rates of respiration between the naïve host and lysogen 
under different nutrient and chemical challenges. Interestingly the φ 24B lysogens acquired the ability to respire 
using Uridine-2-Phosphate where the AURC is illustrated in Fig. 2A and SI Figure 1. U-2-P is involved in cel-
lular metabolism (including biotin metabolism), nucleotide metabolism, pyrimidine metabolism and pyrimi-
dine catabolism55. Phages have been shown to subvert purine and pyrimidine synthesis to aid viral construction 
and proliferation52,56. Lysogen mediated differences encoded by φ 24B also supports these numerous studies as 
metabolomics profiling identifies increased pyrimidine catabolism as 5-methyluridine intensity decreases in the 
lysogen sample. It has also been previously shown through metagenomic analysis that well adapted phages of 
Pseudomonas aeruginosa in the lung carry genes that are involved with purine, pyrimidine and different phos-
phate utilisation57. This is further supported by Chevallereau, et al.58 who show marked changes in RNA metab-
olism during bacteriophage infection of P. aeruginosa58. Importantly, not only does φ 24B lysogen show increased 
pyrimidine utilisation, it also shows that phages can expand the group of phosphates E. coli can use for cell respi-
ration and growth, in this instance U-2-P.
Conversely to addition of function, integration of φ 24B into the MC1061 chromosome confers an inability to 
respire using β -D- allose. The lysogen used in this study has φ 24B inserted into the primary integration site on 
the E. coli genome ~250 bp downstream of intS45. In E. coli there are 3 genes, alsB, alsA, and alsC, that are linked 
to the utilisation of D-allose59, but are disparate (~700 Kbp) from any of the 6 integration sites reported by Fogg 
et al.43,45. This is significant as it illustrates that integration can yield off target epigenetic effects. This study illus-
trates that the lysogen associated changes in fatty acid synthesis may exclude D-allose being transported into the 
bacterial cell, although the mechanism of this restriction is unknown.
Previous research showed infection with λ increased cell growth by the lysogen under cell starvation/sup-
plementation of glucose in a chemostat culture60–62. This increase in growth rate is also seen with φ 24B here. 
Interestingly we see a further increase with infection of a secondary, genetically identical phage. The double 
lysogen is an identical clone to that reported by Fogg et al.43, with phage integrating into the secondary integra-
tion site45. When monitoring growth the single lysogen confers a doubling time of 17 mins compared to 20 mins 
for the naïve MC1061. This is also combined with shorter lag phases in both the single and double lysogen. It has 
previously been shown in many bacteria and yeast that augmenting a growing culture with biotin increases cell 
growth rates63–67.
When stressed with chloroxylenol, a demonstrated increase in lipid biosynthesis occurs in the lysogen pre-
sumably through subversion of the biotin pathway. This is supported through identification of higher intensity 
levels of hexadecanoic acid in the metabolite data. Hexadecanoic acid is involved in the biosynthesis of lipid A, 
Figure 6. Heatmap generated by metabolic levels of 81 metabolites using HCA and DM Culture 
conditions and presence or absence of phage can be found alongside each profile (H = 8-hydroxyquinoline, 
C = chloroxylenol). Each individual tile represents a metabolite. The colour of a given tile denotes higher or 
lower intensity of the metabolite. The colour scale key is: dark blue: lowest levels; white: mid-point; dark red: 
highest level. The gradient between these colours represents variation in the levels of the metabolite across 
the colour scale (putative ID’s can be found in SI Table 3). Pimelic acid is highlighted across all profiles with a 
hatched box.
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a core outer cell membrane structure68–70. Changes in hexadecanoic acid in the lipid A structure of E. coli have 
been previously shown to be associated to mutations in the firA gene69,71. The firA gene is essential for growth 
and outer membrane synthesis72, and is essential for rifampicin resistance associated with certain mutations in 
the β subunit of the RNA polymerase70. This resistance and increase in hexadecanoic acid associated to the firA 
gene, shows that manipulation of this specific fatty acid likely improves antibiotic resistance. It is noteworthy that 
altering cell wall properties can broadly improve drug resistance73, and the biotin pathway is intrinsically linked 
to cell wall synthesis and growth53,74.
The lysogen showed increased tolerance to 8-hydroxyquinoline and chloroxylenol using the Biolog pheno-
typic array and sub-inhibitory antimicrobial tests. An untargeted metabolomics approach demonstrated that 
phage conversion offers the bacterial host different metabolic profiles to tolerate the two antimicrobials tested. 
The tolerance observed also suggests core functional changes allowing the cell to resist two disparate antimicro-
bials. This may suggest that these lysogen associated metabolic differences would likely infer tolerance to other 
environmental challenges and selective pressures.
Firstly, we present a metabolic difference in growth under standard culture conditions between the naïve 
MC1061 and the φ 24B lysogen. From 81 metabolites, 16 were discriminatory between the lysogen and MC1061 
(SI Table 3). Pimelic acid is present and constitutively raised after infection by φ 24B. We also showed here a dif-
ference between metabolites at the 3 key stages of growth. These again differ between the lysogen and MC1061 
(Fig. 6).
Under treatment with chloroxylenol in early growth, increased intensity of hexadecanoic acid was identified, 
particularly in the lysogen. The metabolite sphinganine was observed in our data, sphinganine plays an essential 
part in the sphingolipid synthesis pathway75. In both the lysogen and naïve host there is evidence of higher inten-
sities of a sphinganine under chloroxylenol treatment and at stationary growth in standard conditions (Fig. 6). 
In Shigella species, a pathway associated with mammalian sphingolipid based rafts has been linked to improved 
binding and mammalian host cell entry76.
Metabolic differences between the lysogen and naïve bacteria are the most disparate when under challenge 
of a sub-inhibitory concentration of chloroxylenol, illustrated in the PLS-DA plots (Fig. 4) and heatmap (Fig. 6). 
Chloroxylenol is a bactericidal agent and a halophenol that targets microbial membranes73 with a broad activity 
as an antimicrobial77.
We also demonstrate an increased tolerance by the lysogen to antimicrobial 8-hydroxyquinoline. Interestingly, 
compared to stress under chloroxylenol, the 8-hydroxyquinoline tested metabolite profile changes less signif-
icantly from standard conditions. Furthermore when treated with 8-hydroxyquinoline, the metabolite profile 
is less pronounced in the lysogen when compared to the chloroxylenol test. 8-hydroxyquinoline is a lipophilic 
metal-chelator with intracellular targets78. It inhibits growth by chelating metal ions, e.g. Zn2+ on RNA polymer-
ase79,80. The changes in the intensity of lipids present at the cell surface, that we previously suggested affect uptake 
of D-allose, are similarly likely to inhibit levels of these 2 antimicrobials entering the cell.
When testing cellular stress it is imperative to find markers of inhibition detailed in the metabolite data. 
The metabolomic profiles identified 2 discriminatory metabolites that are associated with cellular stress: 
FAPy-Adenine47 and ophthalmic acid81,82. Our data showed that FAPy-Adenine was only present when cells 
were challenged by the antimicrobials 8-hydroxyquinoline and chloroxylenol. Interestingly the intensity levels 
of FAPy-adenine differ greatly depending on the antimicrobial used and also presence or absence of integrated 
φ 24B (Fig. 5). In the presence of chloroxylenol the lysogen demonstrates lower intensities of the stress marker 
FAPy-adenine, 0.56 and 0.37 fold less in early and mid-exponential growth phase respectively (Figs 2a,b and 5). 
It also shows higher intensity of pimelic acid compared to MC1061. This strengthens the hypothesis of a biotin 
related lipid increase or change at the cell surface lowering levels of the drug reaching its intracellular target.
When challenging the culture with 8-hydroxyquinoline, FAPy-adenine intensity increases rapidly, even more 
so than the naïve host (Fig. 5). Again there is an increase in pimelic acid intensity that is ubiquitous to the meta-
bolic profiles in the presence of an integrated φ 24B. However hexadecanoic acid was undetectable within the cell, 
which may be associated with the lipophilic nature of the drug. The stress response occurs directly after treating 
with 8-hydroxyquinoline and likely promotes some cell death. Extracellular lipids released through cell lysis binds 
the drug, forming a matrix. This therefore would reduce the concentration of the available drug present allowing 
the bacterial culture to grow.
The second stress marker ophthalmic acid is an analogue of glutathione and a reported marker of oxida-
tive stress81,82. Ophthalmic acid intensity mirrored the stationary phase levels of FAPy-adenine, across all tests, 
however it was also present in standard culture conditions in both the early and mid-exponential growth phase 
cultures. This observation from our metabolomic analysis implies higher oxidative stress in the lysogen at station-
ary growth, as the data is supported by Desnues et al.82. The oxidative stress also correlates with the reduction in 
growth rate and a reduction in the intensity of pimelic acid.
This study has established that Stx-phage φ 24B provides a ‘jump start’ in early respiration and increased bacte-
rial growth rates. These phage-mediated alterations in bacterial host metabolic profile may offer positive selection 
for the lysogen. Subversion of the biotin pathway is core to the changes mediated by φ 24B as it links to the bacte-
rium becoming able to tolerate chloroxylenol and 8-hydroxyquinoline during early and mid-exponential growth 
phase. These tolerances are important as both antimicrobials are used globally in livestock farming. Importantly, 
metabolic shift and subversion offers 2 mechanisms of controlling this antimicrobial tolerance through increased 
biotin and fatty acid synthesis. With treatment and tolerance to choloroxylenol, alteration in levels of Lipid A, 
and presumably other lipids enables exclusion of the drug from entry. Secondly 8-hydroxyquinoline treatment 
drives early cellular stress, cell death and lysis which increases extracellular lipids that bind free drug, allowing the 
community to continue to grow.
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The mechanism for this is unclear, yet this is importantly linked to subversion of the bacterial cell because no 
phage encoded metabolites are present. We therefore propose that temperate phages may not carry ARGs but play 
a larger role interfering with metabolic regulation that alters bacterial sensitivity to antimicrobials.
Materials and Methods
Bacterial strains and growth conditions - Buffer and Agar. All bacterial strains were grown in 
Lysogeny Broth + 0.01 M CaCl2 (LB). Growth of the MC1061(φ 24B::Kan), a lysogen of the bacteriophage φ 
24B::Kan and growth of the MC1061(φ 24B::Cat), a lysogen of the bacteriophage φ 24B::Cat was supplemented with 
50 μ g.ml−1 kanamycin (kan) and Chloramphenicol (cat) respectively. Bottom agar plates for plaque assay included 
LB broth including 7% (w/v) grade 1 agar. Soft top agar was contained LB broth plus 0.4% (w/v) grade 1 agar. 
Unless otherwise stated culture conditions were at 37 °C, and broth cultures were shaken at 200 rpm.
Growth curve of single and double lysogens. A single colony of either naïve MC1061, single or double 
lysogen was cultured overnight for 18 h (200 rpm). LB with 0.01 M CaCl2 (100 ml) was inoculated with 1% (v/v) 
of the overnight culture. Samples were taken over a 7 hour period, subject to serial, ten-fold dilutions and spread 
plated on LB agar plates.
Bacterial phenotypic microarray - Biolog. The Biolog assay utilises a redox dye where a tetrazolium 
violet salt acts as an electron receptor from the tricarboxylic cycle and reduction to NADH. The transfer alters the 
clear salt to a purple formazan dye that is inexplicably linked to the cellular activity, specifically cell respiration. 
An inoculum was taken from an 18 h streaked plate of either MC1061 or φ 24B lysogen, raised through 2 rounds 
of passage from single colony amplification from cryo-stock. A single colony was added to fluid IF-0 (containing 
50 μ M leucine due to MC1061’s auxotrophy), to a transmittance of 42% T on a Biolog turbidometer in a 20 mm 
diameter tube as per manufacturer’s instructions and used to inoculate Biolog Phenotypic Microarray plates.
The panel plates used for this study included Biolog plates PM 1–20, which include a range of both metabolic 
and toxicological additives (see SI). Further details of the components associated with these PM plates can be 
found at http://www.biolog.com/pmMicrobialCells.html. The Biolog PM plates were grown at 37 °C and moni-
tored using the Omnilog plate reader at 30 min intervals over 47 hours.
Sub-inhibitory concentration (SIC) assay. An inoculum with a transmittance of 42 % T was created in 
an identical manner to that performed for the Biolog assay for both MC1061 or the lysogen. An identical volume 
of inoculum was added to an equal volume of antimicrobial (double concentrate) diluted in LB broth. Readings 
were taken at 0 and 18 hours; plates were incubated at 37 °C.
SIC assay – Liquid chromatography mass spectrometry (LCMS) analysis comparing metabolic 
compounds from Naïve host and Lysogens. Replicated in triplicate therefore n = 9 bacterial cultures 
(10 ml) were grown as previously described under standard growth conditions and challenged with antimicrobi-
als, the cells were harvested at early, mid, and late log phase. The cells were harvested by centrifugation (5,000 rpm 
for 5 min) and the pellet washed (× 3) in ice cold 1 × PBS prior to lyophilisation. Lyophilised samples (× 3) were 
pooled, normalised for weight/vol (normalised to 1 mg.ml) with methanol and 0.1% formic acid, this was vor-
texed and then sonicated (Bandelin Sonorex, Sonicator) for 1 hour and centrifuged (5 k rpm for 5 mins). The 
supernatant was recovered and filtered through 0.22 μ m pore-sized, nylon filter and injected into the Q-Exactive 
LC-MS (Thermo-Fisher) after separation on a Phenomenex Gemini column (110 A, 150 × 2 mm, 5 μ m, flow 
0.2 ml.min). LCMS mobile phase parameters were: 0–6 mins at 20% ACN, 8 mins 60% ACN, 12 mins 95% ACN, 
17 mins 95% ACN, 17.1 − 23 mins 5% CAN. MS conditions were: full MS mode, resolution 70, 000, AGC target 
1 × 106, maximum IT 200 ms, scan range 150–2000, column temperature 35 °C. Progenesis QI software was used 
for raw data analysis; this software provided alignment, peak picking, pairwise statistical analysis and putative 
metabolite ID based on accurate mass. Metabolites were confirmed by analysing pure standards and MSMS frag-
mentation analysis run under identical analytical conditions.
Biotin quantification assay. Inoculums were prepared in the same manner as for the SIC and Biolog 
assays. Optical density values were taken at 0 and 18 h, incubation at 37 °C. The cultures were diluted to the lowest 
OD600 reading to normalise cell number between naïve MC1061 and lysogen. Dilutions of both naïve MC1061 
and lysogen were made in LB (1:100 and 1:1000). Cells were harvested by centrifugation (5,000 rpm for 5 mins). 
The biotin assay was completed using the Bio Vision® (Cambridge, UK) Biotin Quantitation Kit (Colorimetric) 
according to the manufacturer’s protocol. In brief, the supernatant was discarded and the pellet re-suspended in 
10 μ l PBS and heated to 100 °C for 3 min and then immediately placed on ice. Diluted naïve and lysogen cells (10 μ 
l) were added to individual aliquots of Biotin Assay buffer (20 μ l) and 300 μ l of biotin reaction mix, pre-prepared 
as described in the Biotin Quantitation Kit protocol (version 7.6), was added to the buffer and cells. The mix 
was incubated at 21 °C for 15 min. Each sample mix (150 μ l) was then pipetted into a microtitre plate and read at 
500 nm. A standard curve was prepared as per manufacturer’s instructions.
Statistical analysis. To determine statistically significant difference between growth rates of the single and 
double φ 24B lysogen compared to MC1061, paired-sample T-tests in the statistical package SPSS was used. The 
two tailed p values are given at 95% confidence limits. The statistically significant difference in SIC between 
lysogen and MC1061 was calculated using an independent t-test, using the SPSS platform (> 95% confidence 
limits). The Biolog area under the respiration curve (AURC) for respiration values were calculated using a trape-
zoid algorithm. Statistical significance of area under the respiration curve (AURC) and comparison at a specific 
time point during mid exponential growth phase was achieved by determining normal Gaussian distribution 
by parametric analysis and statistical significance identified using an un-paired t test (> 95% confidence limits). 
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Metabolomic analysis was carried out primarily by Progenesis QI software, this software provided alignment, 
peak picking, pairwise statistical analysis and putative metabolite ID based on accurate mass. Further multivar-
iate analysis was performed using SIMCA-P. ID’s were obtained through the QI plugin ’Progenesis metascope’ 
and filtered through a range of databases using sdf files (ECMDB, HMDB, small molecules drugs, Biomolecules, 
analgesics mix, Lipid MBD, Basic lipids, and Yeast DB). A paired sample t test was used to determine statistically 
significant differences between intensities of metabolites identified during metabolomic analyses (> 95% confi-
dence limits).
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